Three key elements to improve physician outreach
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
Turning claims into interoperable evidence More means more. In a world where anyone can make claims, only taXonomy Pathways makes claims interoperable. That’s the difference between simply collecting data and creating evidence that is complete,...
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
The COVID-19 pandemic illustrated how vital government communications can be for effective public...
As real-world data (RWD) continues to be increasingly utilized by the pharmaceutical industry and...
Medicaid provides much-needed healthcare coverage to over 70 million people, almost half of whom...
The use of real-world data (RWD) in pharmaceutical development is becoming increasingly prevalent...
With the start of 2024, we are moving toward a world without third-party cookies to track consumer...
With recent disruptions in the availability of real-world data (RWD) for clinical research,...
While the CDC is considered the nation’s leading authority on infectious diseases, it is also...
With advances in artificial intelligence (AI) making headlines almost daily, the life sciences...
An interview with Kristijan Kahler, executive director of innovation evidence at Novartis While...